Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urine Test Used to Diagnose Prostate Cancer

By LabMedica International staff writers
Posted on 20 Aug 2012
A novel enzymatic technique for the determination of sarcosine in urine samples could lead to a screening test for prostate cancer. More...


The concentration of the metabolite sarcosine can be determined by treating urine samples with a certain enzyme that interact with a substrate, which causes a chemical reaction that is measurable through different analytical techniques.

Scientists at the Missouri University of Science and Technology (Rolla, MO, USA) developed the technique by using the enzyme sarcosine oxidase on the urine samples to generate formaldehyde, which was further oxidized to formic acid. By observing these chemical reactions and examining the levels of fluorescence after the enzyme treatment, they were able to determine the amount of sarcosine in each of nine urine samples. The more fluorescence in each samples indicated a lower the level of sarcosine, while those with lesser fluorescence suggested a higher level of sarcosine.

Fluorescence emission spectra were obtained with a Fluorstar Omega microplate reader (BMG LABTECH; Ortenberg, Germany) equipped with a xenon lamp. Excitation and emission wavelengths were attuned to 485 nm and 520 nm, respectively. The technique could potentially be used to identify other metabolites associated with prostate cancer, but the findings greatest asset is its simplicity. Effective analysis and quantification of such metabolites in applicable media may then characterize the progression of certain cancers when practical difficulties would otherwise exist.

The scientists concluded that the low cost of their method compared with traditional prostate antigen (PSA) tests also presents a great advantage. They estimate that sarcosine test costs USD 0.1 per sample, compared with the approximately USD 70 it costs to get a PSA test at a health clinic or doctor's office. The article was published online in August 2012 in the journal Analytical Methods.

Related Links:

Missouri University of Science and Technology
BMG LABTECH



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.